The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Mice, SCID

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Mice, SCID.
Olatoyosi Odenike
Connection Strength
0.050
Mice, SCID
  1. Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML. In Vivo. 2022 Jul-Aug; 36(4):1615-1627.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.